Nykode Therapeutics Announces FDA Approval of IND for

FDA approval of IND for VB-C-04 trial.Nykode to further elaborate on trial design and development strategy at upcoming capital markets day in New York on...

Related Keywords

Norway ,Oslo ,Agnete Fredriksen ,Michael Engsig ,Nykode Vaccibody ,Genentech ,Oslo Stock Exchange ,Roche Group ,New York ,Capital Markets Day ,Antigen Presenting Cells ,Nykode Therapeutics ,Business Officer ,Oslo Stock Exchange Nykd ,Ykode Therapeutics Asa ,